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PREVALENS  DARIPADA  OSTEOPENIA DAN  OSTEOPOROSIS: 
PENILAIAN TENTANG PENGETAHUAN, KEPERCAYAAN KESIHATAN 
DAN KECEKAPAN DIRI TERHADAP OSTEOPOROSIS DALAM 
KALANGAN PESAKIT DIABETES MELLITUS JENIS 2  DI PULAU 
PINANG 
 
 
ABSTRAK 
 
Kedua-dua diabetes mellitus jenis 2 (T2DM) dan osteoporosis adalah suatu keadaan 
yang kronik dan perkaitan di antara kedua-duanya juga amat kompleks. Pengetahuan, 
kepercayaan kesihatan dan kecekapan diri terhadap osteoporosis adalah asas kepada 
semua program pengurusan osteoporosis dan ia juga merupakan  prasyarat bagi 
memulakan perubahan tingkah laku. Justeru, matlamat kajian ini adalah untuk 
menilai prevalens keadaan osteoporotik dan tahap pengetahuan, kepercayaan 
kesihatan dan kecekapan diri terhadap osteoporosis dalam kalangan pesakit T2DM di 
Pulau Pinang.   
 
Instrumen yang digunakan untuk menilai tahap pengetahuan, kepercayaan kesihatan 
dan kecekapan diri terhadap osteoporosis adalah  ujian pengetahuan osteoporosis 
(OKT), skala kepercayaan kesihatan osteoporosis (OHBS) dan skala kecekapan diri 
osteoporosis (OSES), masing-masing. Sampel seramai 250 orang pesakit dipilih 
daripada klinik pesakit luar diabetes di Hospital Pulau Pinang (HPP) bagi 
mengesahkan ketiga-tiga skala tersebut (OKT-M, OHBS-M dan OSES-M) dalam 
konteks versi di Malaysia. Suatu prosedur standard ‘forward-backward’ digunakan 
xxxviii 
 
untuk menterjemah skala ke dalam bahasa Melayu. Kebolehpercayaannya diuji bagi 
kekonsistenan dalam dan kesahihan disahkan dengan menggunakan muka, 
kandungan dan kesahihan binaan. Keputusan menunjukkan bahawa 
kebolehpercayaan dan kesahihan adalah boleh diterima. Di samping itu, analisis 
keluk ROC (ciri operasi penerima) digunakan untuk menentukan nilai-potongan (cut-
off value) bagi OKT-M, OHBS-M dan OSES-M dengan kesensitifan dan 
kespesifikan yang optimum untuk membezakan di antara pengetahuan, kepercayaan 
kesihatan dan kecekapan diri, yang tinggi dan rendah terhadap  osteoporosis. Nilai-
potongan OKT-M, OHBS-M dan OSES-M adalah 14, 169, dan 858, masing-masing. 
Kajian ini merumuskan bahawa OKT, OHBS and OSES adalah sah dan boleh 
dipercayai dan boleh digunakan dalam konteks pesakit diabetes di Malaysia.   
 
Sampel seramai 450 orang pesakit T2DM dipilih daripada klinik pesakit luar diabetes 
di HPP untuk menilai status kesihatan tulang melalui pengukuran  BMD (ketumpatan 
mineral tulang) menggunakan QUS, dan juga untuk menilai pengetahuan, 
kepercayaan kesihatan dan kecekapan diri terhadap osteoporosis. Berdasarkan QUS, 
prevalens  BMD normal, osteopenia dan osteoporosis  adalah 18%, 59.8% dan 
22.2%, masing-masing.  
 
Di samping itu, dapatan kajian menunjukkan bahawa 66.70%, 85.60% dan 71.30% 
daripada pesakit T2DM mempunyai tahap yang rendah bagi pengetahuan, 
kepercayaan kesihatan dan kecekapan diri, masing-masing. Tambahan pula, 
perkaitan yang signifikan ditemui di antara skor QUS-T, pengetahuan, kepercayaan 
kesihatan dan kecekapan diri terhadap osteoporosis. Keputusan menunjukkan 
bahawa skor QUS (BMD normal, osteopenia dan osteoporosis) secara subjektif 
xxxix 
 
ditentukan melalui gabungan faktor kognitif dan tingkah laku, dan juga data 
sosiodemografi. Peramal bebas mempunyai perkaitan yang secara statistik adalah 
signifikan untuk membezakan kumpulan osteopenia dan osteoporosis daripada BMD 
normal adalah tempat tinggal, indeks jisim badan (BMI), gender, OKT-M, OSES-M 
dan sejarah keluarga berkenaan dengan patah/ fraktur. Selain itu, umur dan nilai 
HbA1c (kawalan glisemik) adalah ramalan hanya untuk osteoporosis. Hasil kajian ini 
adalah amat penting kerana ia dinyatakan faktor-faktor yang meramalkan keadaan 
osteoporosis dan membantu untuk memulakan tingkah laku pencegahan 
osteoporosis. 
 
Dirumuskan bahawa skor QUS dapat dikaitkan dan terkesan oleh banyak faktor 
dalam kalangan pesakit T2DM.  Justeru,  penyedia penjagaan kesihatan sepatutnya 
memberi tumpuan yang khusus terhadap populasi berisiko tinggi apabila 
mempertimbangkan tentang pengurusan osteoporosis. Usaha gigih perlu diambil 
untuk meningkatkan pengetahuan. kepercayaan perubatan dan kecekapan diri 
terhadap osteoporosisi bagi tingkah laku pencegahan osteoporosis yang berkesan. 
Dapatan kajian menunjukkan bahawa penilaian kesihatan tulang, pengetahuan. 
kepercayaan perubatan dan kecekapan diri pesakit terhadap osteoporosis adalah 
penting dan secara tidak langsung mencerminkan program pendidikan yang 
diperlukan pada masa depan untuk meningkatkan pengurusan osteoporosis.  
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PREVALENCE OF OSTEOPENIA AND OSTEOPOROSIS: THE 
ASSESSMENT OF OSTEOPOROSIS KNOWLEDGE, HEALTH BELIEF 
AND SELF-EFFICACY AMONG PATIENTS WITH TYPE 2 DIABETES 
MELLITUS IN PENANG 
 
 
ABSTRACT 
 
Type 2 diabetes mellitus (T2DM) and osteoporosis are both chronic conditions and 
the relationship between them is complex. Knowledge, health belief and self-efficacy 
toward osteoporosis are fundamental to all osteoporosis management programs and 
are often a pre-requisite for initiating desired behavioural changes. Therefore, the 
aims of the present study were to assess the prevalence of osteoporotic conditions 
and the level of knowledge, health belief and self-efficacy toward osteoporosis 
among T2DM patients in Penang.  
 
The most widely used instruments to assess knowledge, health belief and self-
efficacy toward osteoporosis are the osteoporosis knowledge test (OKT), 
osteoporosis health belief scale (OHBS) and osteoporosis self-efficacy scale (OSES), 
respectively. Thus, a sample of 250 patients was conveniently recruited from the 
outpatient diabetes clinic at Hospital Pulau Pinang (HPP) for the purpose of 
validation of Malaysian versions of these three scales (OKT-M, OHBS-M and 
OSES-M). A standard “forward-backward” procedure was used to translate the 
scales into the Malay language. Reliability was tested for internal consistency and 
xli 
 
validity was confirmed using face, content and construct validity. The results showed 
acceptable reliability and validity. In addition, the receiver operating characteristic 
(ROC) curve analysis was used to determine cut-off values for OKT-M, OHBS-M 
and OSES-M with the optimum sensitivity and specificity to distinguish between 
high and low osteoporosis knowledge, health belief and self-efficacy, respectively. 
The cut-off values of OKT-M, OHBS-M and OSES-M were 14, 169 and 858, 
respectively. This part of the study concluded that OKT, OHBS and OSES were 
valid and reliable and can be used among patients with diabetes in the Malaysian 
setting.  
 
A convenient sample of 450 T2DM patients were recruited from the outpatient 
diabetes clinic at HPP to assess the bone health status by measuring the bone mineral 
density (BMD) using quantitative ultrasound scan (QUS), as well as to evaluate 
osteoporosis knowledge, health belief and self-efficacy. According to QUS, the 
prevalence of normal BMD, osteopenia and osteoporosis were 18%, 59.8% and 
22.2%, respectively.  
 
In addition, the study findings revealed that 66.70%, 85.60% and 71.30% of T2DM 
patients had a low level of osteoporosis knowledge, health belief and self-efficacy, 
respectively. Moreover, significant associations were found between the QUS T-
scores, osteoporosis knowledge, health belief and self-efficacy. The results showed 
that QUS scores (normal BMD, osteopenia and osteoporosis) were subjectively 
determined by a combination of cognitive and behavioural factors, as well as socio-
demographic data. The independent predictors that had a statistically significant 
relationship to distinguish the osteopenia and osteoporosis groups from normal BMD 
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were living place, body mass index (BMI), gender, OKT-M, OSES-M and family 
history of fracture. Moreover, age and HbA1c value (glycaemic control) were 
predictors only for osteoporosis. The results of this study were of great importance as 
it specified the factors that predict osteoporotic conditions and help to initiate 
osteoporosis preventive behaviours.  
 
It is concluded that QUS scores were associated and affected by many factors in 
T2DM patients; therefore, healthcare providers should pay attention to those high 
risk populations when considering osteoporosis management. Extra effort is required 
to improve patients’ knowledge, health belief and self-efficacy toward osteoporosis 
for effective osteoporosis prevention behaviour. The study findings revealed that the 
assessment of T2DM patients’ bone health, knowledge, health belief and self-
efficacy toward osteoporosis are crucial and highlight the required future educational 
programs to improve osteoporosis management. 
1 
 
CHAPTER ONE  
INTRODUCTION 
 
 
1.1 Background of the study 
 
1.1.1 Osteoporosis  
The major contributors to the increase in the rate of chronic disease are an aging 
population as well as a sedentary and unhealthy lifestyle (Bodenheimer et al., 2009). 
The number of people with multiple chronic illnesses is expected to increase from 57 
million in 2000 to 81 million by the year 2020 (Horton, 2009). In addition, more than 
three quarters of all health Medicare expenditure spending is for people with chronic 
conditions (Anderson and Horvath, 2004, Horton, 2009).  
 
Osteoporosis is a chronic disease that represents a major serious public health 
concern due to its prevalence worldwide. Osteoporosis is the most common bone 
disease characterised by low bone mass, microarchitectural deterioration of bone 
tissue, compromised bone strength, and enhanced bone fragility, consequently 
predisposing an individual to an increased risk of fracture (Bouillon et al., 1991, 
Kanis et al., 1994). According to the World Health Organisation (WHO) diagnostic 
classification, osteoporosis is defined as a bone mineral density (BMD) value less 
than or equal to 2.5 standard deviations below the mean BMD of the young adult 
reference population (World Health Organization, 2003). Almost two-thirds of those 
who survive a fracture remain disabled and only 25% will resume normal activities 
(Jensen and Bagger, 1982, Cummings et al., 1985, Clayer and Bauze, 1989).  
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Osteoporosis affects an enormous number of people worldwide. More than 200 
million people have osteoporosis, regardless of race and gender, and its incidence 
will continue to rise as the population ages (Cooper, 1999). In the United States 
(U.S.), by the year 2002, it was estimated that more than 10 million individuals over 
the age of 50 will  have osteoporosis and an additional 34 million individuals are at 
risk of having low bone mass and osteoporosis related-fractures (Cooper, 1999, 
National Osteoporosis Foundation, 2002, Holroyd et al., 2008). By 2020, these 
numbers are estimated to rise to approximately 14 million individuals with 
osteoporosis and more than 47 million cases of low bone mass, as the population 
ages (U.S. Department of Health Human Services, 2004, Lane, 2006, National 
Osteoporosis Foundation, 2013).  
 
Osteoporosis is primarily a woman’s disease, especially postmenopausal women 
(Reginster and Burlet, 2006). In the U.S., eight million American women were 
estimated to have osteoporosis;  women are usually more susceptible to osteoporosis 
as they lose approximately 20% of their bone mass in the first 5-7 years after 
menopause (U.S. Department of Health Human Services, 2004, Dempster, 2011). In 
the U.S. and the European Union, osteoporosis is found in 30% of all 
postmenopausal women, and it is expected that more than 40% of postmenopausal 
women will experience a fracture in later life (Melton et al., 1992). Although 
osteoporosis is more prevalent in women, it can also affect men (Melton 2001). The 
incidence of osteoporosis also increases in men as they get older, with approximately 
2 million American men affected with this disease (U.S. Department of Health 
Human Services, 2004). 
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With regard to ethnicity and osteoporosis risk, 20% of Caucasian, 20% of Asian, 
10% of Hispanic and 5% of African-American women over the age of 50 years have 
osteoporosis. Moreover, 52%, 52%, 49% and 35% of these women, respectively, 
have low bone mass and are at risk of developing osteoporosis (National 
Osteoporosis Foundation, 2013). However, Caucasian and Asian women still bear 
the immense global burden of osteoporosis (U.S. Department of Health Human 
Services, 2004).  
 
Osteoporosis is considered as a silent disease (as it occurs without symptoms) and is 
usually undetected until fracture occurs. All fractures are associated with 
considerable morbidity, lower quality of life, long-term disability (including pain, 
height loss and inability to stand and walk), as well as increased mortality (Barrett-
Connor, 1995, Salkeld et al., 2000, National Institutes of Health, 2001, Colon and 
Saag, 2006). Thus, fractures are the biggest and the most devastating complication 
facing most individuals with osteoporosis (Leibson et al., 2002, Dempster, 2011). 
Worldwide, it is estimated that there were about 1.7 million osteoporosis-related 
fractures in 1990 and this figure is expected to rise to 2.6 million by the year 2025 
(Gullberg et al., 1997, Johnell and Kanis, 2004, U.S. Department of Health Human 
Services, 2004). Moreover, osteoporosis-related fractures account for 0.83% of non-
communicable disease in terms of global burden. The greatest proportion of 
osteoporosis-related fractures are found in Europe (36.6%), whereas Southeast Asia 
(15.5%) and North and South America (16.0%) have a lower prevalence (Johnell and 
Kanis, 2006).  
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In the U.S., the estimated costs of the potential consequences of osteoporosis and 
osteoporosis-related fractures were between $13.7 and $20 billion in 2005; this 
figure is expected to rise to more than $25 billion by 2025 with over 3 million 
fractures as the population ages (Burge et al., 2007, Watts et al., 2010). Moreover, 
one year after fracture surgery, individuals’ annual medical costs are estimated to be 
$14,600 (Gabriel et al., 2002). In the United Kingdom (UK), the medical costs of 
osteoporosis and fractures are expected to be approximately £615 million annually 
(Kanis and Pitt, 1992).  
 
Although the risk of developing osteoporosis is highest in North America and 
Europe, it is expected to rise more in Asian countries as the population ages (Genant 
et al., 1999). The Asian Osteoporosis Study (AOS), which was the first extensive 
study conducted in Asia, showed that the incidence of hip fracture in Hong Kong and 
Singapore was similar to an American Caucasian population (Lau et al., 2001b). A 
recent Asian study showed an increase in mortality risk of hip fracture that persisted 
for 5 years after fracture in both men and women (Koh et al., 2013). In Asia, 
according to the WHO, it was expected that the number of people aged over 65 years 
will be approximately 900 million by the year 2050. Consequently, the figures for 
hip fracture in Asian countries is expected to rise from 30% in 1990 to more than 
50% by the year 2050, with approximately 3.2 million people affected annually 
(Cooper et al., 1992, Gullberg et al., 1997, Lau, 2002).  
 
1.1.2 Diabetes mellitus  
In recent decades, the ability to diagnose and treat diabetes mellitus by medical 
professionals has greatly grown with an increase in medical knowledge and new 
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technologies. However, the effectiveness of this growth is challenged by the 
requirement for patients to change their behaviour. Diabetes mellitus (DM), along 
with other chronic diseases such as cardiovascular diseases (CVD), cancer and 
mental illnesses, now accounts for approximately 47% of the global health burden of 
disease and more than half of all deaths (Darnton-Hill et al., 2004, Wild et al., 2004). 
 
Diabetes is mounting health problem in the contemporary era and its prevalence is 
increasing continuously with a high degree of co-morbidity and mortality (Beckley, 
2006, Hu, 2011). According to the International Diabetes Federation (IDF), 
approximately 366 million people are diabetic and this number is expected to rise to 
approximately 552 million by the year 2030 (Whiting et al., 2011). Moreover, there 
is an increasing in the number of people with impaired glucose tolerance from 344 
million in 2010 to 472 million expected by the year 2030 (Hu, 2011). Moreover, it 
was determined that diabetes mellitus accounted for 12% of worldwide total 
healthcare expenditures, or approximately $376 billion in 2010, and this figure is 
expected to reach $490 billion by the year 2030 (Zhang et al., 2010). Type 2 diabetes 
mellitus (T2DM) accounts for about 90% of the cases of diabetes and is more likely 
to occur in developing countries due to a sedentary lifestyle, aging, obesity and poor 
dietary habits (Darnton-Hill et al., 2004). In addition, most people with diabetes 
cases live in low- and middle-income countries (Hu, 2011).  
 
Diabetes can affect any person of either gender, at any age from any race or socio-
economic background; however, Asian are affected more than Caucasians (Hu, 
2011). In Asia, diabetes accounts for more than 60% of the diabetic population 
worldwide as a consequence of rapid economic growth, urbanisation and nutritional 
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transitions status (Chan et al., 2009). Asians develop diabetes at lower degrees of 
obesity and at younger ages, which means that they suffer longer from complications 
and die sooner than people from other regions (Ko et al., 1999, Yoon et al., 2006, 
Chan et al., 2009). Thus, the prevalence of diabetes in this racially heterogeneous 
population with different demographic, cultural and socio-economic backgrounds has 
rapidly increased among urban and younger people (Wild et al., 2004, Yoon et al., 
2006, Ramachandran et al., 2010, Shaw et al., 2010).  
 
Countries undergoing substantial socio-economic growth and urbanisation are more 
likely to show an increase in the prevalence of diabetes, and data from an 
epidemiological study in Asia has attracted considerable attention to this problem 
(Ramachandran et al., 2010). Urban lifestyles are associated with a lower level of 
physical activity and increased diversity in the diet with more unsaturated and total 
fats and a lower intake of fibre. Chronic diseases like diabetes are diet-related, and 
the effect of poor dietary habits is significant to the aetiology of these diseases (Chan 
et al., 2009). This may lead to a rapid increase in diabetes prevalence within a 
relatively short time. For example, in China, the prevalence of diabetes is expected to 
rise from less than 1% in 1980 to 10% by the 2008, with more than 92 million 
diabetes patients and 148 million people in a prediabetic status (Yang et al., 2010b). 
These results suggest that China has overtaken India and become the global diabetes 
epidemic epicentre. However, in urban areas in the south of India, the prevalence of 
diabetes has reached nearly 20% (Ramachandran et al., 2008). 
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1.2 Osteoporosis and diabetes mellitus in Malaysia 
 
1.2.1 Osteoporosis in Malaysia 
Osteoporosis is considered to be one of the most prevalent and costly diseases across 
Asia, as the population is rapidly increasing and aging (Yeap et al., 2013). The 
prevalence of osteoporosis increases markedly after the age of 50 in postmenopausal 
women in Asia (Kim et al., 2000, Lin et al., 2001, Jang et al., 2006). In Malaysia, the 
prevalence of osteoporosis in postmenopausal women was reported as 24.10% in 
2005, although the prevalence of osteoporosis was much lower in Thailand 
(12.60%), China (16.10%) and Taiwan (10.08%) (Lin et al., 2001, Jang et al., 2006, 
Loh and Shong, 2007). Overall, Asian countries have a higher prevalence of 
osteoporosis than western countries, which may be attributed to the fact that the 
Asian population has a lower body mass index, weight and shorter height (Babbar et 
al., 2006).  
 
In view of the country’s rapidly ageing population, the prevalence of osteoporosis is 
estimated to rise.  In Malaysia, it is expected that the number of people over the age 
of 60 will increase from 1.4 in 1999 to approximately 3.3 million by 2020 (Mafauzy, 
2000, Noor, 2002). Due to rapid urbanisation and economic growth in Malaysia over 
the last three decades, there has been a shift in the diet and lifestyle with an increase 
in the prevalence of chronic diseases (Tee, 1999). Thus, osteoporosis may be 
projected to burden the healthcare system if appropriate intervention and 
management is not undertaken. 
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Moreover, epidemiological studies have estimated an exponential rise in the 
incidence of osteoporosis and fractures in Asia. According to the WHO, by the year 
2050, it is estimated that one out of every two people that experience a fracture in the 
world will live in Asia (Cooper et al., 1992). In Malaysia, it is estimated that the 
incidence of hip fractures among individuals over the age of 50 was 90 per 100,000 
and 500 per 100,000 in people over the age of 75, with direct costs from 
hospitalisation reaching 22 million Ringgit (approximately $ 6 million) in the year 
1997 (Lee and Khir, 2007). With regards to race and the speciﬁc incidence of hip 
fractures in Malaysia, the results show that the incidence is higher among the 
Chinese (160 per 100,000) than Indians (150 per 100,000) and Malays (30 per 
100,000) (Lee and Khir, 2007). Moreover, it is expected that the number of hip 
fractures in women will double as women are more likely to be affected than men, 
with 218 and 88 cases per 100,000 people, respectively (Lau et al., 2001a). No 
Malaysian data are available on the incidence of other fractures due to osteoporosis. 
 
According to the Asian Osteoporosis Study, the rate of hip fractures in Malaysia is 
lower than other in Asian countries (Lau et al., 2001a). However, with urbanisation 
and ageing, this rate is more likely to escalate (Ross, 1996). Moreover, the total 
economic burden of osteoporosis and fractures in Asia has been underestimated, as 
most studies did not account for the costs of rehabilitation and long-term nursing care 
(Mithal et al., 2009a). The best way to control osteoporosis is through aggressive 
prevention strategies targeting high-risk individuals, according to the latest 
Malaysian Clinical Guidance (Yeap et al., 2013). As such, screening and monitoring 
osteoporosis can be important prevention strategies (Summers and Brock, 2005).  
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1.2.2 Diabetes mellitus in Malaysia 
Malaysia is a multi-ethnic country with a total population of 29 million (Department 
of Statistics Malaysia, 2010). In Malaysia, according to the Third National Health 
and Morbidity Survey (NHMS-3), it was estimated that the prevalence of T2DM in 
individuals aged 30 years and over has increased from 8.30% in 1996 to 14.90% by 
the year 2006, with the greatest  increase in the Indian population (Zanariah et al., 
2008, Letchuman et al., 2010). Moreover, it is expected that the number of 
individuals with diabetes will rise from 1,846,000 in 2010 to 3,254,994 in 2030, and 
the adjusted diabetes incidence (adjusted to the world population) in Malaysia will 
increase from 11.6% in 2010 to 13.8% by the year 2030 (International Diabetes 
Federation, 2009). According to the Malaysian Ministry of Health, there has been an 
increase in the prevalence of chronic diseases, including diabetes, within Malaysian 
population (Ministry of Health Malaysia, 2009).  
 
This increase in the prevalence of diabetes is associated with many factors, including 
the rapid economic growth of the country in the last few decades, urbanisation and 
industrialisation, which have resulted in more overweight/obese people and a 
sedentary life style (Ismail et al., 2002, Mustaffa, 2004, Yun et al., 2007, Kee et al., 
2008, Rashid, 2008). In Malaysia, it is estimated that the number of individuals aged 
65 years and over was gradually increased from 4.3% in 2005 to 4.8% in 2007, 
which was much higher than the increase in younger individuals (Yahya et al., 
2008). In this age group, around 25% to 30% of individuals have diabetes or glucose 
intolerance (Wild et al., 2004). 
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Diabetes mellitus can be controlled and managed, but it cannot be cured completely, 
with a combination of medical care, patient education and self-management (Ali and 
Jusoff, 2009, Funnell et al., 2009, Ministry of Health Malaysia, 2009, Shrivastava et 
al., 2013). Multiple diabetes complications in Malaysian T2DM patients have been 
found, with an incidence as high as 38% to 50% (Dhanjal et al., 2001, Mimi et al., 
2003, Ooyub et al., 2004, Mafauzy, 2006a). Out of all the patients who require 
dialysis in Malaysia, 57% are patients with diabetic nephropathy (Lim and Lim, 
2006), and 55% of patients who suffered from stroke also had diabetes (Wong, 1999, 
Hamidon and Raymond, 2003). Diabetes mellitus was eighth in the list of top ten 
causes of death by non-communicable disease in Malaysia (Yusoff et al., 2013). 
Many Malaysian studies that focused on diabetes showed a large proportion of 
patients with poor or suboptimal glycaemic control and a mean HbA1C higher than 
the value recommended by guidelines (Ismail et al., 2000, Chuang et al., 2002, 
Wong and Rahimah, 2004, Tan and Magarey, 2008, Kamarul Imran et al., 2010). 
 
1.3 Osteoporosis care and prevention    
Osteoporosis is a major health problem in Asia. Osteoporosis may arise at any time 
and some of the most important risk factors that may lead to develop osteoporosis 
include genetics, lifestyle, nutrition, inadequate calcium intake and physical activity, 
vitamin D deficiency and decreased production of sex hormones (U.S. Department of 
Health Human Services, 2004, Yeap et al., 2013). Osteoporosis causes serious 
medical complications, not only restricted to the immediate pain resulting from 
fractures, but may also cause a wide range of serious medical consequences and 
affect total quality of life, as shown by many Malaysian studies (Lai et al., 2008, Lai 
et al., 2013). For instance, the surgical procedure for a hip fracture may lead to 
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morbidity and may even cause death due to serious medical complications (Hannan 
et al., 2001). It is estimated that up to 20% of mortality risk is associated with post 
hip fracture complications. In addition, 40% of patients suffer sustained disability 
and a loss of independence, which require long-term nursing care. Therefore, 
osteoporosis-related fractures are considered a major public health problem and 
challenge in Asia (Lau et al., 2001a, Kung et al., 2013). The problem is further 
exacerbated as the overall nutrition and economic situation in these regions have 
shifted over the last few decades, which has led to an excessive increase in health 
care costs and socioeconomic impact due to osteoporotic fractures in Asia (Gullberg 
et al., 1997).   
 
Adaptation of an unhealthy lifestyle such as inadequate regular physical activity and 
low dietary calcium intake have been found to be major risk factors for osteoporotic 
fractures in Asia (Lau et al., 2001b). Moreover, many epidemiological studies have 
identified a high incidence of vitamin D inadequacy and as a results an increased 
incidence of osteoporosis in Asian populations (Mithal et al., 2009b, Chan et al., 
2010, Ho-Pham et al., 2011). Similar results have been found in Malaysian 
postmenopausal women (Rahman et al., 2004). Prevention of osteoporosis should 
begin at birth and continues throughout the lifespan. Thus, to slow down bone loss, 
corrective action must be undertaken by the adaption of a healthy lifestyle including 
regular exercise and adequate dietary calcium intake (Chee et al., 2003, Ting et al., 
2007, Yeap et al., 2013). However, the lack of bone disease awareness in the public 
is one of the biggest problems in term of the prevention of osteoporosis. Moreover, 
there is a common misunderstanding that osteoporosis is a disease only in women 
and in the aged population (Mudano et al., 2003, Qaseem et al., 2008). As a 
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consequence, such an incorrect view may delay the prevention and management of 
osteoporosis. 
 
The prevention of osteoporosis consists of three types: primary, secondary and 
tertiary prevention. Primary prevention involves general management that includes 
the assessment of the risk of falls and their prevention to avert the onset of disease 
(Chang et al., 2004). It includes encouraging adequate calcium and vitamin D intake 
and exercise (Body et al., 2011, Yeap et al., 2013). Secondary prevention involves 
early diagnosis and prompt treatment, including fall prevention and using anabolic 
agents. Tertiary prevention includes comprehensive treatment of fractures and, at this 
level, professional healthcare efforts to retrain and rehabilitate the individual with 
impairments and/or disability (National Institutes of Health, 2001, U.S. Department 
of Health Human Services, 2004, Yeap et al., 2013).  
 
1.4 Osteoporosis knowledge, health belief and self-efficacy 
 
1.4.1 Osteoporosis knowledge 
Information pertaining to the awareness and the level of knowledge regarding bone 
health status and its risk factors are still very limited among adults in Asian (Nguyen 
and O'Connell, 2002) and in Malaysian community-based studies (Jamila et al., 
2010, Yeap et al., 2010). The major obstacles that been identified in the management 
of osteoporosis included a limited level of awareness and knowledge within the 
population, as well as low priority to initiate an appropriate preventive and curative 
plan by healthcare professionals (Cinda  and Sava 2004, Chang et al., 2007, 
Giangregorio et al., 2007, Yeap et al., 2010). Generally, in the chronic disease 
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management area, increased awareness and knowledge about a disease is associated 
with improved patient compliance and adherence by increasing the identification of 
problem and awareness about the decision process (Kennedy and Rogers, 2002).  
 
Several community-based studies have identified a low level of osteoporosis 
knowledge in other countries (Sedlak et al., 2000a, Yu and Huang, 2003, Chang, 
2004, Ailinger et al., 2005, Jalili et al., 2007, Chang, 2008, Aree-Ue and Petlamul, 
2013). Although a good understanding of the disease condition may not be adequate 
to make significant changes in health-related behaviour, knowledge is still a 
prerequisite step for success in adopting and continuing a healthy lifestyle for 
preventive efforts (Gurney and Simmonds, 2007, Ozturk and Sendir, 2011). Thus, 
screening and prevention strategies are cornerstones of appropriate osteoporosis 
management, and education plays a key role in improving osteoporosis outcomes 
(Yeap et al., 2013). 
 
Due to the number of challenges faced by healthcare professionals to implement 
guidance, including a lack of osteoporosis awareness, knowledge, understanding 
responsibilities regarding management and restricted access to diagnostic equipment 
(Levine, 2011), knowledge of osteoporosis is a central part of informed decision 
making on the pharmacological and non-pharmacological aspects of osteoporosis 
management (Body et al., 2011). Therefore, improved information on osteoporosis 
and associated fractures for the high risk populations are important osteoporosis 
preventive strategies. Moreover, many previous studies have shown that a well-
developed educational program is essential for the improvement of osteoporosis 
prevention behaviour and fracture-related outcomes in terms of improving bone 
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health. Thus, an evaluation of the educational needs of patients is an essential first 
step (Piaseu et al., 2001, Aree-Ue et al., 2006). 
 
1.4.2 Osteoporosis health beliefs 
The osteoporosis health beliefs play central roles in osteoporosis prevention and 
behaviour management. Based on health belief model (HBM) theory, health 
behaviour is determined by personal beliefs or perceptions toward the disease and its 
preventive strategies (Janz and Becker, 1984). HBM is the most widely used theory 
in health promotion and educational programmes (Turner et al., 2004). Therefore, 
HBM theory is used in osteoporosis research and practice (Wallace, 2002, Edmonds 
et al., 2012). HBM theory proposes that individual prevention behaviours toward 
osteoporosis increase, if patients feel susceptible, believe that the occurrence of 
osteoporosis would have a severe impact on their lives and conclude that preventive 
measures are beneficial, outweighing any barriers involved in taking action 
(Rosenstock, 1974, Cadarette et al., 2004, Hazavehei et al., 2007, Painter et al., 
2008). 
 
By utilising HBM theory, researchers can investigate and understanding the health 
behaviours and the reasons for non-compliance to osteoporosis prevention programs 
(Turner et al., 2004). Thus, HBM has been used to explain change and provides a 
guiding framework for health behaviour interventions (Glanz et al., 2008). Many 
osteoporosis research studies utilise this model to plan and intervene in populations 
at risk of having osteoporosis in an attempt to determine which variables lead some 
individuals to engage in healthy behaviours and which variables hinder a person’s 
performance (Sedlak et al., 2000a, Chan et al., 2007). In Asia, many studies have 
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shown that most individuals have low osteoporosis health beliefs and they do not 
engage or practice in preventative measures for osteoporosis, which places them at a 
higher risk of low bone mass accruals, even though they are aware that they are 
vulnerable to the risk of osteoporotic fractures in later life (Nguyen and O'Connell, 
2002, Lee and Lai, 2006, Aree-Ue and Petlamul, 2013, Kim et al., 2013). A better 
understanding of the interactions of all these aspects of knowledge, beliefs, dietary 
and lifestyle practices in relation to positive bone health status and osteoporosis 
prevention among individuals will ultimately help them to make a better decisions on 
how to maximise their bone mass during earlier stages of life in order to prevent the 
risk of osteoporosis in later life. 
 
1.4.3 Osteoporosis self-efficacy 
Self-efficacy is refers to an individual’s confidence about their ability to perform a 
particular  behaviour successfully (Bandura, 1977, Bandura, 2004). Therefore, self-
efficacy determines how people think, feel, motivate and behave toward disease. 
Individuals with greater self-efficacy are more likely to motivate and engage in 
healthy behaviours and maintain these behaviours for more positive outcomes and 
less negative outcomes (Luszczynska et al., 2005). The self-efficacy building process 
includes an interaction between emotional states, motivation and outcome 
expectancy (Bandura and Adams, 1977). Self-efficacy contributes to motivation by 
helping people to determine their goals, how much effort they expend, how long they 
persevere in the face of difficulty and their resilience to failures.  
 
Osteoporosis educational intervention programmes is crucial to enhancing 
knowledge and prevention behaviour regarding osteoporosis; as well, it creates the 
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precondition for health behaviour changes (Piaseu et al., 2001). In general, the 
individuals is more likely motivated to act when they realise that changing  their 
behaviour is beneficial to reducing the risk of osteoporosis. This motivation is very 
important in self-efficacy theory (Laslett et al., 2004). Many osteoporosis studies 
have shown that self-efficacy is considered one of the best predictors of health 
behaviours, particularly in terms of increasing physical activity and dietary calcium 
intake (Wallace and Ballard, 2002, Jones et al., 2005, Hsieh et al., 2008). Moreover, 
many community-based studies have shown low self-efficacy toward osteoporosis 
(Piaseu et al., 2001, Brecher et al., 2002, Doheny et al., 2010, Ozturk and Sendir, 
2011, Khorsandi et al., 2012, Aree-Ue and Petlamul, 2013). Therefore, increasing 
self-efficacy perceptions toward osteoporosis are of significant importance in 
osteoporosis preventive behaviours (Sedlak et al., 2000a).  
 
1.5 Research Problems 
Diabetes and osteoporosis management is a lifelong process that requires effort from 
healthcare providers and patients. However, the patient is the key to successful 
management, and serious complications can result from poor management. Patients 
must be proficient to successfully manage, maintain lifestyle changes and make daily 
decisions for better health, while the healthcare professional has the responsibility to 
help patients to make the right decisions and cope with the difficulties and barriers 
through education, support and advice (Funnell and Anderson, 2004, Levine, 2011). 
 
This study has illustrated the following problems: 
1. The proportion of low bone mineral density is high among the general 
population in Asia. As well, the prevalence of osteoporosis in 
17 
 
postmenopausal women in Malaysia is also high. In Malaysia, there has been 
a shortage of data on the topic of the prevalence of osteoporotic conditions 
among T2DM patients.  
2. To date, there have been few academic and empirical published papers 
regarding osteoporosis knowledge, health belief and self-efficacy, and most 
of the reviews on this subject have been conducted in western countries. In 
Malaysia, there has been a lack of data on the topic of patient knowledge, 
health beliefs and self-efficacy regarding osteoporosis among T2DM patients. 
3. No validated Malaysian tools have been found for the assessment of 
osteoporosis knowledge, health beliefs and self-efficacy among T2DM 
patients. 
4. Scarce results have been published regarding the association of bone mineral 
density measurement and osteoporosis knowledge, health beliefs and self-
efficacy in patients with T2DM. 
 
1.6 Rationale of the study 
Osteoporosis is a growing health problem in Malaysia with a high cost in terms of 
economics and disability. In Malaysia, it is estimated that 27,000 people break a hip 
every year because of osteoporosis. The hip fracture incidence among individuals 
aged 50 years and over was 90 per 100,000 with 22 million Ringgit direct 
hospitalisation costs in the year 1997. In addition, it is estimated that the number of 
hip fractures in females is double compared to males (Lau et al., 2001a, Lee and 
Khir, 2007). The prevalence of osteoporosis in Malaysia was 24.10% in 2005, which 
is considerably higher than other Asian countries (Loh and Shong, 2007). This may 
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be due to rapid socio-economic growth, enormous urbanisation and changes in 
dietary habits. 
 
In all countries studies reviewed, there is evidence of underdiagnosed and 
underestimated osteoporosis among the general population (Vestergaard et al., 2005, 
Haussler et al., 2007) and among diabetic patients (Abdulameer et al., 2012c, Luft, 
2012). Many studies have shown that T2DM is related to various skeletal disorders, 
including osteoporosis and osteopenia (Thrailkill et al., 2005, Abdulameer et al., 
2012c, Hamann et al., 2012). Moreover, it has long been known that alterations in 
bone and mineral metabolism are clinically complicated in patients with diabetes 
mellitus (Levin et al., 1976, Ishida et al., 1985, Piepkorn et al., 1997). Many studies 
findings have shown a loss of bone mass that consequently leads to decreased BMD 
and osteoporosis among T2DM patients with poor glycaemic control (Krakauer et 
al., 1995, Linda et al., 2003, Majima et al., 2005). Several mechanisms have been 
proposed for diabetes-related osteoporosis. These include both the co-morbidities of 
diabetes and the more direct pathophysiological effects of the disease itself (Lenchik 
et al., 2003, Inzerillo and Epstein, 2004).  
 
Furthermore, patients with T2DM frequently do not adhere to their prescribed 
medications and, consequently, poor glycaemic control can result, with an increased 
incidence of diabetic complications, increased morbidity and mortality and increased 
health care facilities utilisation (Delamater, 2006, Fowler, 2008, Ahmad et al., 2013). 
Thus, encouraging diabetes self-management and improved glycaemic control play a 
key role in decreasing and protecting bone mass loss in T2DM patients (Gregorio et 
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al., 1994, AL-Elq and Sadat, 2006, Xu et al., 2007, Al-Zaabi et al., 2008, Tao et al., 
2008). 
 
Although numerous measures have been taken to improve bone health and 
osteoporosis management through published Malaysia guideline (Yeap et al., 2013), 
there is a lack of good bone health control and osteoporosis management. In 
Malaysia, it is important to explore patient knowledge, health beliefs and self-
efficacy toward osteoporosis and their awareness by identifying the source of 
information. It is also imperative to understand the contribution of osteoporosis 
knowledge, health beliefs and self-efficacy among T2DM patients regarding bone 
mineral density measurements to promote better osteoporosis prevention behaviour.  
 
Lack of awareness and proper osteoporosis management are responsible for the high 
prevalence of low bone mass (Patel et al., 2004, Winzenberg et al., 2005, Doheny et 
al., 2007, Spencer, 2007). Thus, it has been recommended that osteoporosis 
education should be a component of the diabetes management process by the health 
system as diabetes is a risk factor for developing osteoporosis (Brown and Sharpless, 
2004). Most of the interventions that attempt to improve osteoporosis knowledge, 
health beliefs and self-efficacy in community-based studies were educational 
programs; therefore, for a proper intervention that leads to changes in patient 
behaviour, it is important to first evaluate osteoporosis knowledge, health beliefs and 
self-efficacy among T2DM patients. Osteoporosis prevention behaviour and 
education must be adjusted to the level of knowledge of the patients and should be 
culturally sensitive. 
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1.7 Significance of the study 
As a result of the rapidly growing prevalence of diabetes and osteoporosis with the 
evidence that normal bone mineral density (healthy bone) among T2DM patients is 
associated with reduced morbidity, mortality and disability, osteoporosis prevention 
behaviours have been considered an important part of the management of patients 
with T2DM (Janghorbani et al., 2007, Luisa Isidro and Ruano, 2010, Luft, 2012). 
Currently, osteoporosis is considered a problem in women as well as in men, and 
particularly in elderly persons.  
 
Many educational interventions program for osteoporosis prevention have been 
offered to and evaluated in community level studies. However, osteoporosis in the 
clinical setting is still underdiagnosed, undertreated, under-reported and inadequately 
researched. Even among the Malaysian population with a high risk of osteoporosis, 
the population reported significantly fewer osteoporosis diagnoses than other Asian 
populations (Kung et al., 2013). In Malaysia, elderly patients with osteoporosis-
related fractures are at greater risk for increased disability, high annual costs of 
healthcare, loss of productivity and quality of life; this is a major issue that has to be 
dealt with (Lau et al., 2001a, Seng-Kim, 2009, Yusoff et al., 2013). Therefore, 
screening people with high risk factors of developing osteoporosis like T2DM is 
considered crucial for preventing osteoporosis progression and related fractures. 
 
If no comprehensive prevention strategies are implemented, the prevalence of 
osteoporosis and fractures is estimated to increase by double or triple by 2040 
(Morris et al., 2004, Burge et al., 2007). Many studies have reported that 
osteoporosis-related fractures tend to result in significant morbidity, mortality and 
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financial expense (Caliri et al., 2007, Qaseem et al., 2008, Becker et al., 2010). 
Lifestyle behaviours that influence the development of healthy bones included 
adequate exercise, weight control, balanced nutrition, and adequate calcium and 
vitamin D intake (Elgan et al., 2005, Morgan, 2008, Gracia-Marco et al., 2011, Yeap 
et al., 2013). Health beliefs often influence these lifestyle choices (Sadler and Huff, 
2007). Primary prevention strategies need to be increased and targeted toward groups 
at high risk of developing osteoporosis. Although osteoporosis is considered an 
inevitable disease, it is still vitally important to take effective action to deal with this 
disease, such as a balanced diet containing calcium-rich food and engaging in regular 
physical activity (Levine, 2006, Tung and Lee, 2006). Assessing osteoporosis 
knowledge and the extent to which preventive health behaviours are practiced among 
T2DM patients will give a better comprehensive evaluation of osteoporosis 
management. 
 
However, little is known regarding specific osteoporosis awareness, knowledge, 
health beliefs and self-confidence needed for T2DM patients to effectively 
participate in prevention behaviours. Therefore, the assessment of these is important 
for improving T2DM patient outcomes. This study will attempt to discover the 
association between osteoporosis knowledge, health beliefs and self-efficacy among 
T2DM patients and bone health status. Moreover, there is a lack of research 
concerning osteoporosis knowledge, health beliefs and self-efficacy among T2DM 
patients of both genders and multiple races. This may stem from the majority of 
research being conducted in these areas among healthy individuals or 
postmenopausal elderly women.  
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At the end of this study, healthcare professionals and authorities will have a clearer 
picture of the problems related to osteoporosis in T2DM patients. This study will 
explore patient perceptions of osteoporosis, identify patients with poor osteoporosis 
knowledge, health beliefs and self-efficacy, as well as identify patients with low 
bone mass. The results will help in future planning of educational programs for 
patients with diabetes and help health care providers to concentrate on those patients 
with high risk factors for developing osteoporosis or low bone mass. 
 
1.8 Research objectives and questions 
 
1.8.1 Objective of the study 
Osteoporosis among T2DM patients is a major public health problem that requires 
urgent attention. Patients often do not consider the diabetic condition to be a risk 
factor affecting bone health. Thus, it is important to understand the contribution of 
knowledge, health beliefs and self-efficacy in order to provide better care and 
prevention. To date, scarce data have been published in terms of the assessment of 
osteoporosis knowledge, health beliefs and self-efficacy, as well as its prevalence in 
T2DM patients. Therefore, further exploration of the association between 
osteoporosis knowledge, health beliefs and self-efficacy and the effect of these 
factors on bone mineral density measurement is needed. The principal purpose of the 
study was to investigate the prevalence of low bone mass and to assess osteoporosis 
knowledge, health beliefs and self-efficacy and the association of these factors on 
bone health. The study findings may provide the healthcare system with a better 
understanding of the risk of diabetic disease on bone health status, as well as the 
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effect of osteoporosis knowledge, health beliefs and self-efficacy on bone mineral 
density measurements in patients. 
 
The specific aims of this study are: 
1. To determine the prevalence of low bone mineral density (LBMD, i.e., 
osteopenia and osteoporosis) in T2DM patients using quantitative ultrasound 
method (QUS).  
2. To assess the difference in QUS parameters of the calcaneus stratified by age 
and gender. 
3. To evaluate the correlation between QUS parameters and T-score values with 
patient demographic characteristics, diabetes-related data, and lipid and blood 
pressure profiles. 
4. To evaluate the association between QUS-score (normal BMD, osteopenia 
and osteoporosis) and demographic characteristics, diabetes-related data, lipid 
and blood pressure profiles. 
5. To translate, validate and assess the psychometric properties of the chosen 
tools for the assessment of osteoporosis knowledge, health beliefs and self-
efficacy. 
6. To assess the level of osteoporosis knowledge, health beliefs and self-efficacy 
among patients with type 2 diabetes. 
7. To assess the correlation and differences of demographic characteristics, 
diabetes-related variables as well as lipid and blood pressure profiles with 
osteoporosis knowledge, health beliefs and self-efficacy. 
8. To assess the correlation between osteoporosis knowledge, health beliefs and 
self-efficacy scales and subscales. 
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9. To assess the correlation between T-score values using QUS and osteoporosis 
knowledge, health beliefs and self-efficacy.  
10. To assess the potential factors that predicts the QUS measurement score in 
T2DM patients. 
 
1.8.2 Research questions 
The study addressed the following questions:  
1. Is there a high prevalence of low bone mineral density? What is the 
percentage of osteopenia and osteoporosis in T2DM patients? 
2. Is there a deficiency in osteoporosis knowledge, health beliefs and self-
efficacy among patients with T2DM? 
3. Which of the three variables (osteoporosis knowledge, health beliefs and self-
efficacy), including interactions between variables, account for the most 
variance in predicting bone mineral density measurements? 
4. What is the type and strength of the relationship between patient 
characteristics and osteoporosis knowledge, health beliefs and self-efficacy, 
as well as the outcome (normal bone mineral density)? 
 
1.9 Thesis overview    
In this thesis, chapter 2 reviews the literature related to the study with the definition 
of terms and provides a conceptual framework. A thorough review of literature 
relevant to the study, focusing on the possible relationship between osteoporosis and 
diabetes elsewhere in the world form the bulk of this chapter. The chapter continues 
with an overview of the beneficial use of osteoporosis knowledge, health beliefs and 
self-efficacy in research studies.  
